Global Mesalamine Market Research Report 2021

Report Description


The Global Mesalamine Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Mesalamine Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.
New traders at intervals the Mesalamine Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Mesalamine Market product affairs. The report is at risk of project regarding this Mesalamine Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Allergan
  • Salix Pharmaceuticals
  • Nogra Pharma
  • AstraZeneca
  • Abbvie
  • Takeda
  • Janssen (Johnson & Johnson)
  • Pfizer
  • Ferring
  • Boehringer Ingelheim
  • Cosmo Pharmaceuticals
  • Teva
  • Mylan
  • Sandoz Mesalamine
  • Tillotts Pharma
  • Chiesi Farmaceutici
  • Dr Falk Pharma
  • Cipla
  • Synmosa Biopharma Corporation
  • Lunan Better Pharmaceutical
  • Shanghai Sine Promod Pharmaceutical

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Mesalamine related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Mesalamine Market

Mesalamine Market

Report Highlights:


The Mesalamine Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Mesalamine Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Mesalamine Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Mesalamine Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Mesalamine marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Mesalamine market using a bottom-up approach, wherein manufacturers value data for different type (Capsule, Tablets), of Mesalamine market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Mesalamine Market

Mesalamine Market

Key Target Audience:


  • Mesalamine market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Mesalamine market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Mesalamine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Mesalamine market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Capsule
  • Tablets

By end-user also classify into, the Global Mesalamine market:


Global Mesalamine market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Adult
  • Children

Highlights of this 2021-2027 Mesalamine Market Report:

  • Market dynamics, Mesalamine economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Mesalamine industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Mesalamine Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Mesalamine businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Mesalamine market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com


TableofContents 1MesalamineMarketOverview
1.1ProductOverviewandScopeofMesalamine
1.2MesalamineSegmentbyType
1.2.1GlobalMesalamineSalesGrowthRateComparisonbyType(2021-2027)
1.2.2Capsule
1.2.3Tablets
1.3MesalamineSegmentbyApplication
1.3.1MesalamineSalesComparisonbyApplication:2021VS2027
1.3.2Adult
1.3.3Children
1.4GlobalMesalamineMarketSizeEstimatesandForecasts
1.4.1GlobalMesalamineRevenue2016-2027
1.4.2GlobalMesalamineSales2016-2027
1.4.3MesalamineMarketSizebyRegion:2021Versus2027 2GlobalMesalamineMarketCompetitionbyManufacturers
2.1GlobalMesalamineSalesMarketSharebyManufacturers(2016-2021)
2.2GlobalMesalamineRevenueSharebyManufacturers(2016-2021)
2.3GlobalMesalamineAveragePricebyManufacturers(2016-2021)
2.4ManufacturersMesalamineManufacturingSites,AreaServed,ProductType
2.5MesalamineMarketCompetitiveSituationandTrends
2.5.1MesalamineMarketConcentrationRate
2.5.2GlobalTop5andTop10PlayersMarketSharebyRevenue
2.5.3MarketSharebyCompanyType(Tier1,Tier2andTier3)
2.6ManufacturersMergers&Acquisitions,ExpansionPlans
2.7PrimaryInterviewswithKeyMesalaminePlayers(OpinionLeaders) 3MesalamineRetrospectiveMarketScenariobyRegion
3.1GlobalMesalamineRetrospectiveMarketScenarioinSalesbyRegion:2016-2021
3.2GlobalMesalamineRetrospectiveMarketScenarioinRevenuebyRegion:2016-2021
3.3NorthAmericaMesalamineMarketFacts&FiguresbyCountry
3.3.1NorthAmericaMesalamineSalesbyCountry
3.3.2NorthAmericaMesalamineSalesbyCountry
3.3.3U.S.
3.3.4Canada
3.4EuropeMesalamineMarketFacts&FiguresbyCountry
3.4.1EuropeMesalamineSalesbyCountry
3.4.2EuropeMesalamineSalesbyCountry
3.4.3Germany
3.4.4France
3.4.5U.K.
3.4.6Italy
3.4.7Russia
3.5AsiaPacificMesalamineMarketFacts&FiguresbyRegion
3.5.1AsiaPacificMesalamineSalesbyRegion
3.5.2AsiaPacificMesalamineSalesbyRegion
3.5.3China
3.5.4Japan
3.5.5SouthKorea
3.5.6India
3.5.7Australia
3.5.8Taiwan
3.5.9Indonesia
3.5.10Thailand
3.5.11Malaysia
3.5.12Philippines
3.5.13Vietnam
3.6LatinAmericaMesalamineMarketFacts&FiguresbyCountry
3.6.1LatinAmericaMesalamineSalesbyCountry
3.6.2LatinAmericaMesalamineSalesbyCountry
3.6.3Mexico
3.6.3Brazil
3.6.3Argentina
3.7MiddleEastandAfricaMesalamineMarketFacts&FiguresbyCountry
3.7.1MiddleEastandAfricaMesalamineSalesbyCountry
3.7.2MiddleEastandAfricaMesalamineSalesbyCountry
3.7.3Turkey
3.7.4SaudiArabia
3.7.5U.A.E 4GlobalMesalamineHistoricMarketAnalysisbyType
4.1GlobalMesalamineSalesMarketSharebyType(2016-2021)
4.2GlobalMesalamineRevenueMarketSharebyType(2016-2021)
4.3GlobalMesalaminePriceMarketSharebyType(2016-2021)
4.4GlobalMesalamineMarketSharebyPriceTier(2016-2021):Low-End,Mid-RangeandHigh-End 5GlobalMesalamineHistoricMarketAnalysisbyApplication
5.1GlobalMesalamineSalesMarketSharebyApplication(2016-2021)
5.2GlobalMesalamineRevenueMarketSharebyApplication(2016-2021)
5.3GlobalMesalaminePricebyApplication(2016-2021) 6CompanyProfilesandKeyFiguresinMesalamineBusiness
6.1Allergan
6.1.1CorporationInformation
6.1.2AllerganDescription,BusinessOverviewandTotalRevenue
6.1.3AllerganMesalamineSales,RevenueandGrossMargin(2016-2021)
6.1.4AllerganProductsOffered
6.1.5AllerganRecentDevelopment
6.2SalixPharmaceuticals
6.2.1SalixPharmaceuticalsMesalamineProductionSitesandAreaServed
6.2.2SalixPharmaceuticalsDescription,BusinessOverviewandTotalRevenue
6.2.3SalixPharmaceuticalsMesalamineSales,RevenueandGrossMargin(2016-2021)
6.2.4SalixPharmaceuticalsProductsOffered
6.2.5SalixPharmaceuticalsRecentDevelopment
6.3NograPharma
6.3.1NograPharmaMesalamineProductionSitesandAreaServed
6.3.2NograPharmaDescription,BusinessOverviewandTotalRevenue
6.3.3NograPharmaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.3.4NograPharmaProductsOffered
6.3.5NograPharmaRecentDevelopment
6.4AstraZeneca
6.4.1AstraZenecaMesalamineProductionSitesandAreaServed
6.4.2AstraZenecaDescription,BusinessOverviewandTotalRevenue
6.4.3AstraZenecaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.4.4AstraZenecaProductsOffered
6.4.5AstraZenecaRecentDevelopment
6.5Abbvie
6.5.1AbbvieMesalamineProductionSitesandAreaServed
6.5.2AbbvieDescription,BusinessOverviewandTotalRevenue
6.5.3AbbvieMesalamineSales,RevenueandGrossMargin(2016-2021)
6.5.4AbbvieProductsOffered
6.5.5AbbvieRecentDevelopment
6.6Takeda
6.6.1TakedaMesalamineProductionSitesandAreaServed
6.6.2TakedaDescription,BusinessOverviewandTotalRevenue
6.6.3TakedaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.6.4TakedaProductsOffered
6.6.5TakedaRecentDevelopment
6.7Janssen(Johnson&Johnson)
6.6.1Janssen(Johnson&Johnson)MesalamineProductionSitesandAreaServed
6.6.2Janssen(Johnson&Johnson)Description,BusinessOverviewandTotalRevenue
6.6.3Janssen(Johnson&Johnson)MesalamineSales,RevenueandGrossMargin(2016-2021)
6.4.4Janssen(Johnson&Johnson)ProductsOffered
6.7.5Janssen(Johnson&Johnson)RecentDevelopment
6.8Pfizer
6.8.1PfizerMesalamineProductionSitesandAreaServed
6.8.2PfizerDescription,BusinessOverviewandTotalRevenue
6.8.3PfizerMesalamineSales,RevenueandGrossMargin(2016-2021)
6.8.4PfizerProductsOffered
6.8.5PfizerRecentDevelopment
6.9Ferring
6.9.1FerringMesalamineProductionSitesandAreaServed
6.9.2FerringDescription,BusinessOverviewandTotalRevenue
6.9.3FerringMesalamineSales,RevenueandGrossMargin(2016-2021)
6.9.4FerringProductsOffered
6.9.5FerringRecentDevelopment
6.10BoehringerIngelheim
6.10.1BoehringerIngelheimMesalamineProductionSitesandAreaServed
6.10.2BoehringerIngelheimDescription,BusinessOverviewandTotalRevenue
6.10.3BoehringerIngelheimMesalamineSales,RevenueandGrossMargin(2016-2021)
6.10.4BoehringerIngelheimProductsOffered
6.10.5BoehringerIngelheimRecentDevelopment
6.11CosmoPharmaceuticals
6.11.1CosmoPharmaceuticalsMesalamineProductionSitesandAreaServed
6.11.2CosmoPharmaceuticalsMesalamineDescription,BusinessOverviewandTotalRevenue
6.11.3CosmoPharmaceuticalsMesalamineSales,RevenueandGrossMargin(2016-2021)
6.11.4CosmoPharmaceuticalsProductsOffered
6.11.5CosmoPharmaceuticalsRecentDevelopment
6.12Teva
6.12.1TevaMesalamineProductionSitesandAreaServed
6.12.2TevaMesalamineDescription,BusinessOverviewandTotalRevenue
6.12.3TevaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.12.4TevaProductsOffered
6.12.5TevaRecentDevelopment
6.13Mylan
6.13.1MylanMesalamineProductionSitesandAreaServed
6.13.2MylanMesalamineDescription,BusinessOverviewandTotalRevenue
6.13.3MylanMesalamineSales,RevenueandGrossMargin(2016-2021)
6.13.4MylanProductsOffered
6.13.5MylanRecentDevelopment
6.14SandozMesalamine
6.14.1SandozMesalamineMesalamineProductionSitesandAreaServed
6.14.2SandozMesalamineMesalamineDescription,BusinessOverviewandTotalRevenue
6.14.3SandozMesalamineMesalamineSales,RevenueandGrossMargin(2016-2021)
6.14.4SandozMesalamineProductsOffered
6.14.5SandozMesalamineRecentDevelopment
6.15TillottsPharma
6.15.1TillottsPharmaMesalamineProductionSitesandAreaServed
6.15.2TillottsPharmaMesalamineDescription,BusinessOverviewandTotalRevenue
6.15.3TillottsPharmaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.15.4TillottsPharmaProductsOffered
6.15.5TillottsPharmaRecentDevelopment
6.16ChiesiFarmaceutici
6.16.1ChiesiFarmaceuticiMesalamineProductionSitesandAreaServed
6.16.2ChiesiFarmaceuticiMesalamineDescription,BusinessOverviewandTotalRevenue
6.16.3ChiesiFarmaceuticiMesalamineSales,RevenueandGrossMargin(2016-2021)
6.16.4ChiesiFarmaceuticiProductsOffered
6.16.5ChiesiFarmaceuticiRecentDevelopment
6.17DrFalkPharma
6.17.1DrFalkPharmaMesalamineProductionSitesandAreaServed
6.17.2DrFalkPharmaMesalamineDescription,BusinessOverviewandTotalRevenue
6.17.3DrFalkPharmaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.17.4DrFalkPharmaProductsOffered
6.17.5DrFalkPharmaRecentDevelopment
6.18Cipla
6.18.1CiplaMesalamineProductionSitesandAreaServed
6.18.2CiplaMesalamineDescription,BusinessOverviewandTotalRevenue
6.18.3CiplaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.18.4CiplaProductsOffered
6.18.5CiplaRecentDevelopment
6.19SynmosaBiopharmaCorporation
6.19.1SynmosaBiopharmaCorporationMesalamineProductionSitesandAreaServed
6.19.2SynmosaBiopharmaCorporationMesalamineDescription,BusinessOverviewandTotalRevenue
6.19.3SynmosaBiopharmaCorporationMesalamineSales,RevenueandGrossMargin(2016-2021)
6.19.4SynmosaBiopharmaCorporationProductsOffered
6.19.5SynmosaBiopharmaCorporationRecentDevelopment
6.20LunanBetterPharmaceutical
6.20.1LunanBetterPharmaceuticalMesalamineProductionSitesandAreaServed
6.20.2LunanBetterPharmaceuticalMesalamineDescription,BusinessOverviewandTotalRevenue
6.20.3LunanBetterPharmaceuticalMesalamineSales,RevenueandGrossMargin(2016-2021)
6.20.4LunanBetterPharmaceuticalProductsOffered
6.20.5LunanBetterPharmaceuticalRecentDevelopment
6.21ShanghaiSinePromodPharmaceutical
6.21.1ShanghaiSinePromodPharmaceuticalMesalamineProductionSitesandAreaServed
6.21.2ShanghaiSinePromodPharmaceuticalMesalamineDescription,BusinessOverviewandTotalRevenue
6.21.3ShanghaiSinePromodPharmaceuticalMesalamineSales,RevenueandGrossMargin(2016-2021)
6.21.4ShanghaiSinePromodPharmaceuticalProductsOffered
6.21.5ShanghaiSinePromodPharmaceuticalRecentDevelopment 7MesalamineManufacturingCostAnalysis
7.1MesalamineKeyRawMaterialsAnalysis
7.1.1KeyRawMaterials
7.1.2KeyRawMaterialsPriceTrend
7.1.3KeySuppliersofRawMaterials
7.2ProportionofManufacturingCostStructure
7.3ManufacturingProcessAnalysisofMesalamine
7.4MesalamineIndustrialChainAnalysis 8MarketingChannel,DistributorsandCustomers
8.1MarketingChannel
8.2MesalamineDistributorsList
8.3MesalamineCustomers 9MarketDynamics 9.1MarketTrends 9.2OpportunitiesandDrivers 9.3Challenges 9.4Porter'sFiveForcesAnalysis 10GlobalMarketForecast
10.1GlobalMesalamineMarketEstimatesandProjectionsbyType
10.1.1GlobalForecastedSalesofMesalaminebyType(2021-2027)
10.1.2GlobalForecastedRevenueofMesalaminebyType(2021-2027)
10.2MesalamineMarketEstimatesandProjectionsbyApplication
10.2.1GlobalForecastedSalesofMesalaminebyApplication(2021-2027)
10.2.2GlobalForecastedRevenueofMesalaminebyApplication(2021-2027)
10.3MesalamineMarketEstimatesandProjectionsbyRegion
10.3.1GlobalForecastedSalesofMesalaminebyRegion(2021-2027)
10.3.2GlobalForecastedRevenueofMesalaminebyRegion(2021-2027)
10.4NorthAmericaMesalamineEstimatesandProjections(2021-2027)
10.5EuropeMesalamineEstimatesandProjections(2021-2027)
10.6AsiaPacificMesalamineEstimatesandProjections(2021-2027)
10.7LatinAmericaMesalamineEstimatesandProjections(2021-2027)
10.8MiddleEastandAfricaMesalamineEstimatesandProjections(2021-2027) 11ResearchFindingandConclusion 12MethodologyandDataSource 12.1Methodology/ResearchApproach 12.1.1ResearchPrograms/Design 12.1.2MarketSizeEstimation 12.1.3MarketBreakdownandDataTriangulation 12.2DataSource 12.2.1SecondarySources 12.2.2PrimarySources 12.3AuthorList 12.4Disclaimer


List of Tables
Table 1. Global Mesalamine Sales (KG) Growth Rate Comparison by Type (2016-2027)
Table 2. Global Mesalamine Sales (KG) Comparison by Application: 2021 VS 2027
Table 3. Global Mesalamine Market Size by Type (KG) (US$ Million) (2021 VS 2027)
Table 4. Global Key Mesalamine Manufacturers Covered in This Study
Table 5. Global Mesalamine Sales (KG) by Manufacturers (2016-2021)
Table 6. Global Mesalamine Sales Share by Manufacturers (2016-2021)
Table 7. Global Mesalamine Revenue (Million USD) by Manufacturers (2016-2021)
Table 8. Global Mesalamine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Mesalamine Average Price (USD/KG) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Mesalamine Sales Sites and Area Served
Table 11. Manufacturers Mesalamine Product Types
Table 12. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2020)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Mesalamine Players
Table 16. Global Mesalamine Sales (KG) by Region (2016-2021)
Table 17. Global Mesalamine Sales Market Share by Region (2016-2021)
Table 18. Global Mesalamine Revenue (Million US$) by Region (2016-2021)
Table 19. Global Mesalamine Revenue Market Share by Region (2016-2021)
Table 20. North America Mesalamine Sales by Country (2016-2021) (KG)
Table 21. North America Mesalamine Sales Market Share by Country (2016-2021)
Table 22. North America Mesalamine Revenue by Country (2016-2021) (US$ Million)
Table 23. North America Mesalamine Revenue Market Share by Country (2016-2021)
Table 24. Europe Mesalamine Sales by Country (2016-2021) (KG)
Table 25. Europe Mesalamine Sales Market Share by Country (2016-2021)
Table 26. Europe Mesalamine Revenue by Country (2016-2021) (US$ Million)
Table 27. Europe Mesalamine Revenue Market Share by Country (2016-2021)
Table 28. Asia Pacific Mesalamine Sales by Region (2016-2021) (KG)
Table 29. Asia Pacific Mesalamine Sales Market Share by Region (2016-2021)
Table 30. Asia Pacific Mesalamine Revenue by Region (2016-2021) (US$ Million)
Table 31. Asia Pacific Mesalamine Revenue Market Share by Region (2016-2021)
Table 32. Latin America Mesalamine Sales by Country (2016-2021) (KG)
Table 33. Latin America Mesalamine Sales Market Share by Country (2016-2021)
Table 34. Latin America Mesalamine Revenue by Country (2016-2021) (US$ Million)
Table 35. Latin America Mesalamine Revenue Market Share by Country (2016-2021)
Table 36. Middle East and Africa Mesalamine Sales by Country (2016-2021) (KG)
Table 37. Middle East and Africa Mesalamine Sales Market Share by Country (2016-2021)
Table 38. Middle East and Africa Mesalamine Revenue by Country (2016-2021) (US$ Million)
Table 39. Middle East and Africa Mesalamine Revenue Market Share by Country (2016-2021)
Table 40. Global Mesalamine Sales (KG) by Type (2016-2021)
Table 41. Global Mesalamine Sales Share by Type (2016-2021)
Table 42. Global Mesalamine Revenue (Million US$) by Type (2016-2021)
Table 43. Global Mesalamine Revenue Share by Type (2016-2021)
Table 44. Global Mesalamine Price (USD/KG) by Type (2016-2021)
Table 45. Global Mesalamine Sales (KG) by Application (2016-2021)
Table 46. Global Mesalamine Sales Market Share by Application (2016-2021)
Table 47. Global Mesalamine Sales Growth Rate by Application (2016-2021)
Table 48. Allergan Mesalamine Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 51. Allergan Main Product
Table 52. Allergan Recent Development
Table 53. Salix Pharmaceuticals Mesalamine Corporation Information
Table 54. Salix Pharmaceuticals Corporation Information
Table 55. Salix Pharmaceuticals Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 56. Salix Pharmaceuticals Main Product
Table 57. Salix Pharmaceuticals Recent Development
Table 58. Nogra Pharma Mesalamine Corporation Information
Table 59. Nogra Pharma Corporation Information
Table 60. Nogra Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 61. Nogra Pharma Main Product
Table 62. Nogra Pharma Recent Development
Table 63. AstraZeneca Mesalamine Corporation Information
Table 64. AstraZeneca Corporation Information
Table 65. AstraZeneca Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 66. AstraZeneca Main Product
Table 67. AstraZeneca Recent Development
Table 68. Abbvie Mesalamine Corporation Information
Table 69. Abbvie Corporation Information
Table 70. Abbvie Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 71. Abbvie Main Product
Table 72. Abbvie Recent Development
Table 73. Takeda Mesalamine Corporation Information
Table 74. Takeda Corporation Information
Table 75. Takeda Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 76. Takeda Main Product
Table 77. Takeda Recent Development
Table 78. Janssen (Johnson & Johnson) Mesalamine Corporation Information
Table 79. Janssen (Johnson & Johnson) Corporation Information
Table 80. Janssen (Johnson & Johnson) Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 81. Janssen (Johnson & Johnson) Main Product
Table 82. Janssen (Johnson & Johnson) Recent Development
Table 83. Pfizer Mesalamine Corporation Information
Table 84. Pfizer Corporation Information
Table 85. Pfizer Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 86. Pfizer Main Product
Table 87. Pfizer Recent Development
Table 88. Ferring Mesalamine Corporation Information
Table 89. Ferring Corporation Information
Table 90. Ferring Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 91. Ferring Main Product
Table 92. Ferring Recent Development
Table 93. Boehringer Ingelheim Mesalamine Corporation Information
Table 94. Boehringer Ingelheim Corporation Information
Table 95. Boehringer Ingelheim Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 96. Boehringer Ingelheim Main Product
Table 97. Boehringer Ingelheim Recent Development
Table 98. Cosmo Pharmaceuticals Mesalamine Corporation Information
Table 99. Cosmo Pharmaceuticals Corporation Information
Table 100. Cosmo Pharmaceuticals Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 101. Cosmo Pharmaceuticals Main Product
Table 102. Cosmo Pharmaceuticals Recent Development
Table 103. Teva Mesalamine Corporation Information
Table 104. Teva Corporation Information
Table 105. Teva Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 106. Teva Main Product
Table 107. Teva Recent Development
Table 108. Mylan Mesalamine Corporation Information
Table 109. Mylan Corporation Information
Table 110. Mylan Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 111. Mylan Main Product
Table 112. Mylan Recent Development
Table 113. Sandoz Mesalamine Mesalamine Corporation Information
Table 114. Sandoz Mesalamine Corporation Information
Table 115. Sandoz Mesalamine Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 116. Sandoz Mesalamine Main Product
Table 117. Sandoz Mesalamine Recent Development
Table 118. Tillotts Pharma Mesalamine Corporation Information
Table 119. Tillotts Pharma Corporation Information
Table 120. Tillotts Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 121. Tillotts Pharma Main Product
Table 122. Tillotts Pharma Recent Development
Table 123. Chiesi Farmaceutici Mesalamine Corporation Information
Table 124. Chiesi Farmaceutici Corporation Information
Table 125. Chiesi Farmaceutici Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 126. Chiesi Farmaceutici Main Product
Table 127. Chiesi Farmaceutici Recent Development
Table 128. Dr Falk Pharma Mesalamine Corporation Information
Table 129. Dr Falk Pharma Corporation Information
Table 130. Dr Falk Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 131. Dr Falk Pharma Main Product
Table 132. Dr Falk Pharma Recent Development
Table 133. Cipla Mesalamine Corporation Information
Table 134. Cipla Corporation Information
Table 135. Cipla Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 136. Cipla Main Product
Table 137. Cipla Recent Development
Table 138. Synmosa Biopharma Corporation Mesalamine Corporation Information
Table 139. Synmosa Biopharma Corporation Corporation Information
Table 140. Synmosa Biopharma Corporation Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 141. Synmosa Biopharma Corporation Main Product
Table 142. Synmosa Biopharma Corporation Recent Development
Table 143. Lunan Better Pharmaceutical Mesalamine Corporation Information
Table 144. Lunan Better Pharmaceutical Corporation Information
Table 145. Lunan Better Pharmaceutical Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 146. Lunan Better Pharmaceutical Main Product
Table 147. Lunan Better Pharmaceutical Recent Development
Table 148. Shanghai Sine Promod Pharmaceutical Mesalamine Corporation Information
Table 149. Shanghai Sine Promod Pharmaceutical Corporation Information
Table 150. Shanghai Sine Promod Pharmaceutical Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 151. Shanghai Sine Promod Pharmaceutical Main Product
Table 152. Shanghai Sine Promod Pharmaceutical Recent Development
Table 153. Sales Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Mesalamine Distributors List
Table 156. Mesalamine Customers List
Table 157. Market Key Trends
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2027)
Table 159. Key Challenges
Table 160. Global Mesalamine Sales (KG) Forecast by Type (2021-2027)
Table 161. Global Mesalamine Sales Market Share Forecast by Type (2021-2027)
Table 162. Global Mesalamine Revenue (Million US$) Forecast by Type (2021-2027)
Table 163. Global Mesalamine Revenue (Million US$) Market Share Forecast by Type (2021-2027)
Table 164. Global Mesalamine Sales (KG) Forecast by Application (2021-2027)
Table 165. Global Mesalamine Revenue (Million US$) Forecast by Application (2021-2027)
Table 166. Global Mesalamine Sales (KG) Forecast by Region (2021-2027)
Table 167. Global Mesalamine Sales Market Share Forecast by Region (2021-2027)
Table 168. Global Mesalamine Revenue Forecast by Region (2021-2027) (US$ Million)
Table 169. Global Mesalamine Revenue Market Share Forecast by Region (2021-2027)
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Mesalamine
Figure 2. Global Mesalamine Sales Market Share by Type: 2021 VS 2027
Figure 3. Capsule Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Mesalamine Consumption Market Share by Application: 2021 VS 2027
Figure 6. Adult
Figure 7. Children
Figure 8. Global Mesalamine Market Size 2016-2027 (US$ Million)
Figure 9. Global Mesalamine Sales Capacity (KG) (2016-2027)
Figure 10. Global Mesalamine Market Size Market Share by Region: 2021 Versus 2027
Figure 11. Mesalamine Sales Share by Manufacturers in 2021
Figure 12. Global Mesalamine Revenue Share by Manufacturers in 2020
Figure 13. The Global 5 and 10 Largest Players: Market Share by Mesalamine Revenue in 2020
Figure 14. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 15. Global Mesalamine Sales Market Share by Region (2016-2021)
Figure 16. Global Mesalamine Sales Market Share by Region in 2020
Figure 17. Global Mesalamine Revenue Market Share by Region (2016-2021)
Figure 18. Global Mesalamine Revenue Market Share by Region in 2020
Figure 19. North America Mesalamine Sales Market Share by Country in 2020
Figure 20. North America Mesalamine Revenue Market Share by Country in 2020
Figure 21. U.S. Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 22. U.S. Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 24. Canada Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Europe Mesalamine Sales Market Share by Country in 2020
Figure 26. Europe Mesalamine Revenue Market Share by Country in 2020
Figure 27. Germany Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 28. Germany Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 30. France Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 32. U.K. Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 34. Italy Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Russia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 36. Russia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Asia Pacific Mesalamine Sales Market Share by Region in 2020
Figure 38. Asia Pacific Mesalamine Revenue Market Share by Region in 2020
Figure 39. China Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 40. China Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Japan Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 42. Japan Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. South Korea Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 44. South Korea Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. India Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 46. India Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Australia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 48. Australia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Taiwan Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 50. Taiwan Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Indonesia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 52. Indonesia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. Thailand Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 54. Thailand Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Malaysia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 56. Malaysia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Philippines Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 58. Philippines Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Vietnam Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 60. Vietnam Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Latin America Mesalamine Sales Market Share by Country in 2020
Figure 62. Latin America Mesalamine Revenue Market Share by Country in 2020
Figure 63. Mexico Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 64. Mexico Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Brazil Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 66. Brazil Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Argentina Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 68. Argentina Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Middle East and Africa Mesalamine Sales Market Share by Country in 2020
Figure 70. Middle East and Africa Mesalamine Revenue Market Share by Country in 2020
Figure 71. Turkey Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 72. Turkey Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Saudi Arabia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 74. Saudi Arabia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. U.A.E Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 76. U.A.E Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Sales Market Share of Mesalamine by Type (2016-2021)
Figure 78. Sales Market Share of Mesalamine by Type in 2020
Figure 79. Revenue Share of Mesalamine by Type (2016-2021)
Figure 80. Revenue Market Share of Mesalamine by Type in 2020
Figure 81. Global Mesalamine Sales Growth by Type (2016-2021) (KG)
Figure 82. Global Mesalamine Sales Market Share by Application (2016-2021)
Figure 83. Global Mesalamine Sales Market Share by Application in 2020
Figure 84. Global Revenue Share of Mesalamine by Application (2016-2021)
Figure 85. Global Revenue Share of Mesalamine by Application in 2021
Figure 86. Allergan Total Revenue (US$ Million): 2020 Compared with 2018
Figure 87. Salix Pharmaceuticals Total Revenue (US$ Million): 2020 Compared with 2018
Figure 88. Nogra Pharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 89. AstraZeneca Total Revenue (US$ Million): 2020 Compared with 2018
Figure 90. Abbvie Total Revenue (US$ Million): 2020 Compared with 2018
Figure 91. Takeda Total Revenue (US$ Million): 2020 Compared with 2018
Figure 92. Janssen (Johnson & Johnson) Total Revenue (US$ Million): 2020 Compared with 2018
Figure 93. Pfizer Total Revenue (US$ Million): 2020 Compared with 2018
Figure 94. Ferring Total Revenue (US$ Million): 2020 Compared with 2018
Figure 95. Boehringer Ingelheim Total Revenue (US$ Million): 2020 Compared with 2018
Figure 96. Cosmo Pharmaceuticals Total Revenue (US$ Million): 2020 Compared with 2018
Figure 97. Teva Total Revenue (US$ Million): 2020 Compared with 2018
Figure 98. Mylan Total Revenue (US$ Million): 2020 Compared with 2018
Figure 99. Sandoz Mesalamine Total Revenue (US$ Million): 2020 Compared with 2018
Figure 100. Tillotts Pharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 101. Chiesi Farmaceutici Total Revenue (US$ Million): 2020 Compared with 2018
Figure 102. Dr Falk Pharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 103. Cipla Total Revenue (US$ Million): 2020 Compared with 2018
Figure 104. Synmosa Biopharma Corporation Total Revenue (US$ Million): 2020 Compared with 2018
Figure 105. Lunan Better Pharmaceutical Total Revenue (US$ Million): 2020 Compared with 2018
Figure 106. Shanghai Sine Promod Pharmaceutical Total Revenue (US$ Million): 2020 Compared with 2018
Figure 107. Price Trend of Key Raw Materials
Figure 108. Manufacturing Cost Structure of Mesalamine
Figure 109. Manufacturing Process Analysis of Mesalamine
Figure 110. Mesalamine Industrial Chain Analysis
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Porter's Five Forces Analysis
Figure 114. North America Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 115. North America Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 116. Europe Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 117. Europe Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 118. Latin America Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 119. Latin America Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 120. Middle East and Africa Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 121. Middle East and Africa Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 122. Asia Pacific Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 123. Asia Pacific Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

Mesalamine Market Segments


Mesalamine Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Capsule
  • Tablets

Mesalamine Application Outlook (Revenue, USD Million, 2021 2027)


  • Adult
  • Children

Mesalamine Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

  • Europe
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

  • Asia Pacific
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

  • Latin America
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

  • Middle East & Africa
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Mesalamine Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Mesalamine Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.
New traders at intervals the Mesalamine Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Mesalamine Market product affairs. The report is at risk of project regarding this Mesalamine Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Allergan
  • Salix Pharmaceuticals
  • Nogra Pharma
  • AstraZeneca
  • Abbvie
  • Takeda
  • Janssen (Johnson & Johnson)
  • Pfizer
  • Ferring
  • Boehringer Ingelheim
  • Cosmo Pharmaceuticals
  • Teva
  • Mylan
  • Sandoz Mesalamine
  • Tillotts Pharma
  • Chiesi Farmaceutici
  • Dr Falk Pharma
  • Cipla
  • Synmosa Biopharma Corporation
  • Lunan Better Pharmaceutical
  • Shanghai Sine Promod Pharmaceutical

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Mesalamine related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Mesalamine Market

Mesalamine Market

Report Highlights:


The Mesalamine Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Mesalamine Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Mesalamine Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Mesalamine Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Mesalamine marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Mesalamine market using a bottom-up approach, wherein manufacturers value data for different type (Capsule, Tablets), of Mesalamine market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Mesalamine Market

Mesalamine Market

Key Target Audience:


  • Mesalamine market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Mesalamine market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Mesalamine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Mesalamine market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Capsule
  • Tablets

By end-user also classify into, the Global Mesalamine market:


Global Mesalamine market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Adult
  • Children

Highlights of this 2021-2027 Mesalamine Market Report:

  • Market dynamics, Mesalamine economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Mesalamine industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Mesalamine Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Mesalamine businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Mesalamine market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

TableofContents 1MesalamineMarketOverview
1.1ProductOverviewandScopeofMesalamine
1.2MesalamineSegmentbyType
1.2.1GlobalMesalamineSalesGrowthRateComparisonbyType(2021-2027)
1.2.2Capsule
1.2.3Tablets
1.3MesalamineSegmentbyApplication
1.3.1MesalamineSalesComparisonbyApplication:2021VS2027
1.3.2Adult
1.3.3Children
1.4GlobalMesalamineMarketSizeEstimatesandForecasts
1.4.1GlobalMesalamineRevenue2016-2027
1.4.2GlobalMesalamineSales2016-2027
1.4.3MesalamineMarketSizebyRegion:2021Versus2027 2GlobalMesalamineMarketCompetitionbyManufacturers
2.1GlobalMesalamineSalesMarketSharebyManufacturers(2016-2021)
2.2GlobalMesalamineRevenueSharebyManufacturers(2016-2021)
2.3GlobalMesalamineAveragePricebyManufacturers(2016-2021)
2.4ManufacturersMesalamineManufacturingSites,AreaServed,ProductType
2.5MesalamineMarketCompetitiveSituationandTrends
2.5.1MesalamineMarketConcentrationRate
2.5.2GlobalTop5andTop10PlayersMarketSharebyRevenue
2.5.3MarketSharebyCompanyType(Tier1,Tier2andTier3)
2.6ManufacturersMergers&Acquisitions,ExpansionPlans
2.7PrimaryInterviewswithKeyMesalaminePlayers(OpinionLeaders) 3MesalamineRetrospectiveMarketScenariobyRegion
3.1GlobalMesalamineRetrospectiveMarketScenarioinSalesbyRegion:2016-2021
3.2GlobalMesalamineRetrospectiveMarketScenarioinRevenuebyRegion:2016-2021
3.3NorthAmericaMesalamineMarketFacts&FiguresbyCountry
3.3.1NorthAmericaMesalamineSalesbyCountry
3.3.2NorthAmericaMesalamineSalesbyCountry
3.3.3U.S.
3.3.4Canada
3.4EuropeMesalamineMarketFacts&FiguresbyCountry
3.4.1EuropeMesalamineSalesbyCountry
3.4.2EuropeMesalamineSalesbyCountry
3.4.3Germany
3.4.4France
3.4.5U.K.
3.4.6Italy
3.4.7Russia
3.5AsiaPacificMesalamineMarketFacts&FiguresbyRegion
3.5.1AsiaPacificMesalamineSalesbyRegion
3.5.2AsiaPacificMesalamineSalesbyRegion
3.5.3China
3.5.4Japan
3.5.5SouthKorea
3.5.6India
3.5.7Australia
3.5.8Taiwan
3.5.9Indonesia
3.5.10Thailand
3.5.11Malaysia
3.5.12Philippines
3.5.13Vietnam
3.6LatinAmericaMesalamineMarketFacts&FiguresbyCountry
3.6.1LatinAmericaMesalamineSalesbyCountry
3.6.2LatinAmericaMesalamineSalesbyCountry
3.6.3Mexico
3.6.3Brazil
3.6.3Argentina
3.7MiddleEastandAfricaMesalamineMarketFacts&FiguresbyCountry
3.7.1MiddleEastandAfricaMesalamineSalesbyCountry
3.7.2MiddleEastandAfricaMesalamineSalesbyCountry
3.7.3Turkey
3.7.4SaudiArabia
3.7.5U.A.E 4GlobalMesalamineHistoricMarketAnalysisbyType
4.1GlobalMesalamineSalesMarketSharebyType(2016-2021)
4.2GlobalMesalamineRevenueMarketSharebyType(2016-2021)
4.3GlobalMesalaminePriceMarketSharebyType(2016-2021)
4.4GlobalMesalamineMarketSharebyPriceTier(2016-2021):Low-End,Mid-RangeandHigh-End 5GlobalMesalamineHistoricMarketAnalysisbyApplication
5.1GlobalMesalamineSalesMarketSharebyApplication(2016-2021)
5.2GlobalMesalamineRevenueMarketSharebyApplication(2016-2021)
5.3GlobalMesalaminePricebyApplication(2016-2021) 6CompanyProfilesandKeyFiguresinMesalamineBusiness
6.1Allergan
6.1.1CorporationInformation
6.1.2AllerganDescription,BusinessOverviewandTotalRevenue
6.1.3AllerganMesalamineSales,RevenueandGrossMargin(2016-2021)
6.1.4AllerganProductsOffered
6.1.5AllerganRecentDevelopment
6.2SalixPharmaceuticals
6.2.1SalixPharmaceuticalsMesalamineProductionSitesandAreaServed
6.2.2SalixPharmaceuticalsDescription,BusinessOverviewandTotalRevenue
6.2.3SalixPharmaceuticalsMesalamineSales,RevenueandGrossMargin(2016-2021)
6.2.4SalixPharmaceuticalsProductsOffered
6.2.5SalixPharmaceuticalsRecentDevelopment
6.3NograPharma
6.3.1NograPharmaMesalamineProductionSitesandAreaServed
6.3.2NograPharmaDescription,BusinessOverviewandTotalRevenue
6.3.3NograPharmaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.3.4NograPharmaProductsOffered
6.3.5NograPharmaRecentDevelopment
6.4AstraZeneca
6.4.1AstraZenecaMesalamineProductionSitesandAreaServed
6.4.2AstraZenecaDescription,BusinessOverviewandTotalRevenue
6.4.3AstraZenecaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.4.4AstraZenecaProductsOffered
6.4.5AstraZenecaRecentDevelopment
6.5Abbvie
6.5.1AbbvieMesalamineProductionSitesandAreaServed
6.5.2AbbvieDescription,BusinessOverviewandTotalRevenue
6.5.3AbbvieMesalamineSales,RevenueandGrossMargin(2016-2021)
6.5.4AbbvieProductsOffered
6.5.5AbbvieRecentDevelopment
6.6Takeda
6.6.1TakedaMesalamineProductionSitesandAreaServed
6.6.2TakedaDescription,BusinessOverviewandTotalRevenue
6.6.3TakedaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.6.4TakedaProductsOffered
6.6.5TakedaRecentDevelopment
6.7Janssen(Johnson&Johnson)
6.6.1Janssen(Johnson&Johnson)MesalamineProductionSitesandAreaServed
6.6.2Janssen(Johnson&Johnson)Description,BusinessOverviewandTotalRevenue
6.6.3Janssen(Johnson&Johnson)MesalamineSales,RevenueandGrossMargin(2016-2021)
6.4.4Janssen(Johnson&Johnson)ProductsOffered
6.7.5Janssen(Johnson&Johnson)RecentDevelopment
6.8Pfizer
6.8.1PfizerMesalamineProductionSitesandAreaServed
6.8.2PfizerDescription,BusinessOverviewandTotalRevenue
6.8.3PfizerMesalamineSales,RevenueandGrossMargin(2016-2021)
6.8.4PfizerProductsOffered
6.8.5PfizerRecentDevelopment
6.9Ferring
6.9.1FerringMesalamineProductionSitesandAreaServed
6.9.2FerringDescription,BusinessOverviewandTotalRevenue
6.9.3FerringMesalamineSales,RevenueandGrossMargin(2016-2021)
6.9.4FerringProductsOffered
6.9.5FerringRecentDevelopment
6.10BoehringerIngelheim
6.10.1BoehringerIngelheimMesalamineProductionSitesandAreaServed
6.10.2BoehringerIngelheimDescription,BusinessOverviewandTotalRevenue
6.10.3BoehringerIngelheimMesalamineSales,RevenueandGrossMargin(2016-2021)
6.10.4BoehringerIngelheimProductsOffered
6.10.5BoehringerIngelheimRecentDevelopment
6.11CosmoPharmaceuticals
6.11.1CosmoPharmaceuticalsMesalamineProductionSitesandAreaServed
6.11.2CosmoPharmaceuticalsMesalamineDescription,BusinessOverviewandTotalRevenue
6.11.3CosmoPharmaceuticalsMesalamineSales,RevenueandGrossMargin(2016-2021)
6.11.4CosmoPharmaceuticalsProductsOffered
6.11.5CosmoPharmaceuticalsRecentDevelopment
6.12Teva
6.12.1TevaMesalamineProductionSitesandAreaServed
6.12.2TevaMesalamineDescription,BusinessOverviewandTotalRevenue
6.12.3TevaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.12.4TevaProductsOffered
6.12.5TevaRecentDevelopment
6.13Mylan
6.13.1MylanMesalamineProductionSitesandAreaServed
6.13.2MylanMesalamineDescription,BusinessOverviewandTotalRevenue
6.13.3MylanMesalamineSales,RevenueandGrossMargin(2016-2021)
6.13.4MylanProductsOffered
6.13.5MylanRecentDevelopment
6.14SandozMesalamine
6.14.1SandozMesalamineMesalamineProductionSitesandAreaServed
6.14.2SandozMesalamineMesalamineDescription,BusinessOverviewandTotalRevenue
6.14.3SandozMesalamineMesalamineSales,RevenueandGrossMargin(2016-2021)
6.14.4SandozMesalamineProductsOffered
6.14.5SandozMesalamineRecentDevelopment
6.15TillottsPharma
6.15.1TillottsPharmaMesalamineProductionSitesandAreaServed
6.15.2TillottsPharmaMesalamineDescription,BusinessOverviewandTotalRevenue
6.15.3TillottsPharmaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.15.4TillottsPharmaProductsOffered
6.15.5TillottsPharmaRecentDevelopment
6.16ChiesiFarmaceutici
6.16.1ChiesiFarmaceuticiMesalamineProductionSitesandAreaServed
6.16.2ChiesiFarmaceuticiMesalamineDescription,BusinessOverviewandTotalRevenue
6.16.3ChiesiFarmaceuticiMesalamineSales,RevenueandGrossMargin(2016-2021)
6.16.4ChiesiFarmaceuticiProductsOffered
6.16.5ChiesiFarmaceuticiRecentDevelopment
6.17DrFalkPharma
6.17.1DrFalkPharmaMesalamineProductionSitesandAreaServed
6.17.2DrFalkPharmaMesalamineDescription,BusinessOverviewandTotalRevenue
6.17.3DrFalkPharmaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.17.4DrFalkPharmaProductsOffered
6.17.5DrFalkPharmaRecentDevelopment
6.18Cipla
6.18.1CiplaMesalamineProductionSitesandAreaServed
6.18.2CiplaMesalamineDescription,BusinessOverviewandTotalRevenue
6.18.3CiplaMesalamineSales,RevenueandGrossMargin(2016-2021)
6.18.4CiplaProductsOffered
6.18.5CiplaRecentDevelopment
6.19SynmosaBiopharmaCorporation
6.19.1SynmosaBiopharmaCorporationMesalamineProductionSitesandAreaServed
6.19.2SynmosaBiopharmaCorporationMesalamineDescription,BusinessOverviewandTotalRevenue
6.19.3SynmosaBiopharmaCorporationMesalamineSales,RevenueandGrossMargin(2016-2021)
6.19.4SynmosaBiopharmaCorporationProductsOffered
6.19.5SynmosaBiopharmaCorporationRecentDevelopment
6.20LunanBetterPharmaceutical
6.20.1LunanBetterPharmaceuticalMesalamineProductionSitesandAreaServed
6.20.2LunanBetterPharmaceuticalMesalamineDescription,BusinessOverviewandTotalRevenue
6.20.3LunanBetterPharmaceuticalMesalamineSales,RevenueandGrossMargin(2016-2021)
6.20.4LunanBetterPharmaceuticalProductsOffered
6.20.5LunanBetterPharmaceuticalRecentDevelopment
6.21ShanghaiSinePromodPharmaceutical
6.21.1ShanghaiSinePromodPharmaceuticalMesalamineProductionSitesandAreaServed
6.21.2ShanghaiSinePromodPharmaceuticalMesalamineDescription,BusinessOverviewandTotalRevenue
6.21.3ShanghaiSinePromodPharmaceuticalMesalamineSales,RevenueandGrossMargin(2016-2021)
6.21.4ShanghaiSinePromodPharmaceuticalProductsOffered
6.21.5ShanghaiSinePromodPharmaceuticalRecentDevelopment 7MesalamineManufacturingCostAnalysis
7.1MesalamineKeyRawMaterialsAnalysis
7.1.1KeyRawMaterials
7.1.2KeyRawMaterialsPriceTrend
7.1.3KeySuppliersofRawMaterials
7.2ProportionofManufacturingCostStructure
7.3ManufacturingProcessAnalysisofMesalamine
7.4MesalamineIndustrialChainAnalysis 8MarketingChannel,DistributorsandCustomers
8.1MarketingChannel
8.2MesalamineDistributorsList
8.3MesalamineCustomers 9MarketDynamics 9.1MarketTrends 9.2OpportunitiesandDrivers 9.3Challenges 9.4Porter'sFiveForcesAnalysis 10GlobalMarketForecast
10.1GlobalMesalamineMarketEstimatesandProjectionsbyType
10.1.1GlobalForecastedSalesofMesalaminebyType(2021-2027)
10.1.2GlobalForecastedRevenueofMesalaminebyType(2021-2027)
10.2MesalamineMarketEstimatesandProjectionsbyApplication
10.2.1GlobalForecastedSalesofMesalaminebyApplication(2021-2027)
10.2.2GlobalForecastedRevenueofMesalaminebyApplication(2021-2027)
10.3MesalamineMarketEstimatesandProjectionsbyRegion
10.3.1GlobalForecastedSalesofMesalaminebyRegion(2021-2027)
10.3.2GlobalForecastedRevenueofMesalaminebyRegion(2021-2027)
10.4NorthAmericaMesalamineEstimatesandProjections(2021-2027)
10.5EuropeMesalamineEstimatesandProjections(2021-2027)
10.6AsiaPacificMesalamineEstimatesandProjections(2021-2027)
10.7LatinAmericaMesalamineEstimatesandProjections(2021-2027)
10.8MiddleEastandAfricaMesalamineEstimatesandProjections(2021-2027) 11ResearchFindingandConclusion 12MethodologyandDataSource 12.1Methodology/ResearchApproach 12.1.1ResearchPrograms/Design 12.1.2MarketSizeEstimation 12.1.3MarketBreakdownandDataTriangulation 12.2DataSource 12.2.1SecondarySources 12.2.2PrimarySources 12.3AuthorList 12.4Disclaimer

Mesalamine Market Segments


Mesalamine Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Capsule
  • Tablets

Mesalamine Application Outlook (Revenue, USD Million, 2021 2027)


  • Adult
  • Children

Mesalamine Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

  • Europe
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

  • Asia Pacific
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

  • Latin America
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

  • Middle East & Africa
    • Mesalamine market, By Product Type Outlook
      • Capsule
      • Tablets

    • Mesalamine market, By Application Outlook
      • Adult
      • Children

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

List of Tables
Table 1. Global Mesalamine Sales (KG) Growth Rate Comparison by Type (2016-2027)
Table 2. Global Mesalamine Sales (KG) Comparison by Application: 2021 VS 2027
Table 3. Global Mesalamine Market Size by Type (KG) (US$ Million) (2021 VS 2027)
Table 4. Global Key Mesalamine Manufacturers Covered in This Study
Table 5. Global Mesalamine Sales (KG) by Manufacturers (2016-2021)
Table 6. Global Mesalamine Sales Share by Manufacturers (2016-2021)
Table 7. Global Mesalamine Revenue (Million USD) by Manufacturers (2016-2021)
Table 8. Global Mesalamine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Mesalamine Average Price (USD/KG) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Mesalamine Sales Sites and Area Served
Table 11. Manufacturers Mesalamine Product Types
Table 12. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2020)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Mesalamine Players
Table 16. Global Mesalamine Sales (KG) by Region (2016-2021)
Table 17. Global Mesalamine Sales Market Share by Region (2016-2021)
Table 18. Global Mesalamine Revenue (Million US$) by Region (2016-2021)
Table 19. Global Mesalamine Revenue Market Share by Region (2016-2021)
Table 20. North America Mesalamine Sales by Country (2016-2021) (KG)
Table 21. North America Mesalamine Sales Market Share by Country (2016-2021)
Table 22. North America Mesalamine Revenue by Country (2016-2021) (US$ Million)
Table 23. North America Mesalamine Revenue Market Share by Country (2016-2021)
Table 24. Europe Mesalamine Sales by Country (2016-2021) (KG)
Table 25. Europe Mesalamine Sales Market Share by Country (2016-2021)
Table 26. Europe Mesalamine Revenue by Country (2016-2021) (US$ Million)
Table 27. Europe Mesalamine Revenue Market Share by Country (2016-2021)
Table 28. Asia Pacific Mesalamine Sales by Region (2016-2021) (KG)
Table 29. Asia Pacific Mesalamine Sales Market Share by Region (2016-2021)
Table 30. Asia Pacific Mesalamine Revenue by Region (2016-2021) (US$ Million)
Table 31. Asia Pacific Mesalamine Revenue Market Share by Region (2016-2021)
Table 32. Latin America Mesalamine Sales by Country (2016-2021) (KG)
Table 33. Latin America Mesalamine Sales Market Share by Country (2016-2021)
Table 34. Latin America Mesalamine Revenue by Country (2016-2021) (US$ Million)
Table 35. Latin America Mesalamine Revenue Market Share by Country (2016-2021)
Table 36. Middle East and Africa Mesalamine Sales by Country (2016-2021) (KG)
Table 37. Middle East and Africa Mesalamine Sales Market Share by Country (2016-2021)
Table 38. Middle East and Africa Mesalamine Revenue by Country (2016-2021) (US$ Million)
Table 39. Middle East and Africa Mesalamine Revenue Market Share by Country (2016-2021)
Table 40. Global Mesalamine Sales (KG) by Type (2016-2021)
Table 41. Global Mesalamine Sales Share by Type (2016-2021)
Table 42. Global Mesalamine Revenue (Million US$) by Type (2016-2021)
Table 43. Global Mesalamine Revenue Share by Type (2016-2021)
Table 44. Global Mesalamine Price (USD/KG) by Type (2016-2021)
Table 45. Global Mesalamine Sales (KG) by Application (2016-2021)
Table 46. Global Mesalamine Sales Market Share by Application (2016-2021)
Table 47. Global Mesalamine Sales Growth Rate by Application (2016-2021)
Table 48. Allergan Mesalamine Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 51. Allergan Main Product
Table 52. Allergan Recent Development
Table 53. Salix Pharmaceuticals Mesalamine Corporation Information
Table 54. Salix Pharmaceuticals Corporation Information
Table 55. Salix Pharmaceuticals Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 56. Salix Pharmaceuticals Main Product
Table 57. Salix Pharmaceuticals Recent Development
Table 58. Nogra Pharma Mesalamine Corporation Information
Table 59. Nogra Pharma Corporation Information
Table 60. Nogra Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 61. Nogra Pharma Main Product
Table 62. Nogra Pharma Recent Development
Table 63. AstraZeneca Mesalamine Corporation Information
Table 64. AstraZeneca Corporation Information
Table 65. AstraZeneca Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 66. AstraZeneca Main Product
Table 67. AstraZeneca Recent Development
Table 68. Abbvie Mesalamine Corporation Information
Table 69. Abbvie Corporation Information
Table 70. Abbvie Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 71. Abbvie Main Product
Table 72. Abbvie Recent Development
Table 73. Takeda Mesalamine Corporation Information
Table 74. Takeda Corporation Information
Table 75. Takeda Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 76. Takeda Main Product
Table 77. Takeda Recent Development
Table 78. Janssen (Johnson & Johnson) Mesalamine Corporation Information
Table 79. Janssen (Johnson & Johnson) Corporation Information
Table 80. Janssen (Johnson & Johnson) Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 81. Janssen (Johnson & Johnson) Main Product
Table 82. Janssen (Johnson & Johnson) Recent Development
Table 83. Pfizer Mesalamine Corporation Information
Table 84. Pfizer Corporation Information
Table 85. Pfizer Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 86. Pfizer Main Product
Table 87. Pfizer Recent Development
Table 88. Ferring Mesalamine Corporation Information
Table 89. Ferring Corporation Information
Table 90. Ferring Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 91. Ferring Main Product
Table 92. Ferring Recent Development
Table 93. Boehringer Ingelheim Mesalamine Corporation Information
Table 94. Boehringer Ingelheim Corporation Information
Table 95. Boehringer Ingelheim Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 96. Boehringer Ingelheim Main Product
Table 97. Boehringer Ingelheim Recent Development
Table 98. Cosmo Pharmaceuticals Mesalamine Corporation Information
Table 99. Cosmo Pharmaceuticals Corporation Information
Table 100. Cosmo Pharmaceuticals Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 101. Cosmo Pharmaceuticals Main Product
Table 102. Cosmo Pharmaceuticals Recent Development
Table 103. Teva Mesalamine Corporation Information
Table 104. Teva Corporation Information
Table 105. Teva Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 106. Teva Main Product
Table 107. Teva Recent Development
Table 108. Mylan Mesalamine Corporation Information
Table 109. Mylan Corporation Information
Table 110. Mylan Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 111. Mylan Main Product
Table 112. Mylan Recent Development
Table 113. Sandoz Mesalamine Mesalamine Corporation Information
Table 114. Sandoz Mesalamine Corporation Information
Table 115. Sandoz Mesalamine Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 116. Sandoz Mesalamine Main Product
Table 117. Sandoz Mesalamine Recent Development
Table 118. Tillotts Pharma Mesalamine Corporation Information
Table 119. Tillotts Pharma Corporation Information
Table 120. Tillotts Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 121. Tillotts Pharma Main Product
Table 122. Tillotts Pharma Recent Development
Table 123. Chiesi Farmaceutici Mesalamine Corporation Information
Table 124. Chiesi Farmaceutici Corporation Information
Table 125. Chiesi Farmaceutici Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 126. Chiesi Farmaceutici Main Product
Table 127. Chiesi Farmaceutici Recent Development
Table 128. Dr Falk Pharma Mesalamine Corporation Information
Table 129. Dr Falk Pharma Corporation Information
Table 130. Dr Falk Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 131. Dr Falk Pharma Main Product
Table 132. Dr Falk Pharma Recent Development
Table 133. Cipla Mesalamine Corporation Information
Table 134. Cipla Corporation Information
Table 135. Cipla Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 136. Cipla Main Product
Table 137. Cipla Recent Development
Table 138. Synmosa Biopharma Corporation Mesalamine Corporation Information
Table 139. Synmosa Biopharma Corporation Corporation Information
Table 140. Synmosa Biopharma Corporation Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 141. Synmosa Biopharma Corporation Main Product
Table 142. Synmosa Biopharma Corporation Recent Development
Table 143. Lunan Better Pharmaceutical Mesalamine Corporation Information
Table 144. Lunan Better Pharmaceutical Corporation Information
Table 145. Lunan Better Pharmaceutical Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 146. Lunan Better Pharmaceutical Main Product
Table 147. Lunan Better Pharmaceutical Recent Development
Table 148. Shanghai Sine Promod Pharmaceutical Mesalamine Corporation Information
Table 149. Shanghai Sine Promod Pharmaceutical Corporation Information
Table 150. Shanghai Sine Promod Pharmaceutical Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 151. Shanghai Sine Promod Pharmaceutical Main Product
Table 152. Shanghai Sine Promod Pharmaceutical Recent Development
Table 153. Sales Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Mesalamine Distributors List
Table 156. Mesalamine Customers List
Table 157. Market Key Trends
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2027)
Table 159. Key Challenges
Table 160. Global Mesalamine Sales (KG) Forecast by Type (2021-2027)
Table 161. Global Mesalamine Sales Market Share Forecast by Type (2021-2027)
Table 162. Global Mesalamine Revenue (Million US$) Forecast by Type (2021-2027)
Table 163. Global Mesalamine Revenue (Million US$) Market Share Forecast by Type (2021-2027)
Table 164. Global Mesalamine Sales (KG) Forecast by Application (2021-2027)
Table 165. Global Mesalamine Revenue (Million US$) Forecast by Application (2021-2027)
Table 166. Global Mesalamine Sales (KG) Forecast by Region (2021-2027)
Table 167. Global Mesalamine Sales Market Share Forecast by Region (2021-2027)
Table 168. Global Mesalamine Revenue Forecast by Region (2021-2027) (US$ Million)
Table 169. Global Mesalamine Revenue Market Share Forecast by Region (2021-2027)
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Mesalamine
Figure 2. Global Mesalamine Sales Market Share by Type: 2021 VS 2027
Figure 3. Capsule Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Mesalamine Consumption Market Share by Application: 2021 VS 2027
Figure 6. Adult
Figure 7. Children
Figure 8. Global Mesalamine Market Size 2016-2027 (US$ Million)
Figure 9. Global Mesalamine Sales Capacity (KG) (2016-2027)
Figure 10. Global Mesalamine Market Size Market Share by Region: 2021 Versus 2027
Figure 11. Mesalamine Sales Share by Manufacturers in 2021
Figure 12. Global Mesalamine Revenue Share by Manufacturers in 2020
Figure 13. The Global 5 and 10 Largest Players: Market Share by Mesalamine Revenue in 2020
Figure 14. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 15. Global Mesalamine Sales Market Share by Region (2016-2021)
Figure 16. Global Mesalamine Sales Market Share by Region in 2020
Figure 17. Global Mesalamine Revenue Market Share by Region (2016-2021)
Figure 18. Global Mesalamine Revenue Market Share by Region in 2020
Figure 19. North America Mesalamine Sales Market Share by Country in 2020
Figure 20. North America Mesalamine Revenue Market Share by Country in 2020
Figure 21. U.S. Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 22. U.S. Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 24. Canada Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Europe Mesalamine Sales Market Share by Country in 2020
Figure 26. Europe Mesalamine Revenue Market Share by Country in 2020
Figure 27. Germany Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 28. Germany Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 30. France Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 32. U.K. Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 34. Italy Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Russia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 36. Russia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Asia Pacific Mesalamine Sales Market Share by Region in 2020
Figure 38. Asia Pacific Mesalamine Revenue Market Share by Region in 2020
Figure 39. China Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 40. China Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Japan Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 42. Japan Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. South Korea Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 44. South Korea Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. India Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 46. India Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Australia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 48. Australia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Taiwan Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 50. Taiwan Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Indonesia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 52. Indonesia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. Thailand Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 54. Thailand Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Malaysia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 56. Malaysia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Philippines Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 58. Philippines Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Vietnam Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 60. Vietnam Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Latin America Mesalamine Sales Market Share by Country in 2020
Figure 62. Latin America Mesalamine Revenue Market Share by Country in 2020
Figure 63. Mexico Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 64. Mexico Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Brazil Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 66. Brazil Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Argentina Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 68. Argentina Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Middle East and Africa Mesalamine Sales Market Share by Country in 2020
Figure 70. Middle East and Africa Mesalamine Revenue Market Share by Country in 2020
Figure 71. Turkey Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 72. Turkey Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Saudi Arabia Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 74. Saudi Arabia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. U.A.E Mesalamine Sales Growth Rate (2016-2021) (KG)
Figure 76. U.A.E Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Sales Market Share of Mesalamine by Type (2016-2021)
Figure 78. Sales Market Share of Mesalamine by Type in 2020
Figure 79. Revenue Share of Mesalamine by Type (2016-2021)
Figure 80. Revenue Market Share of Mesalamine by Type in 2020
Figure 81. Global Mesalamine Sales Growth by Type (2016-2021) (KG)
Figure 82. Global Mesalamine Sales Market Share by Application (2016-2021)
Figure 83. Global Mesalamine Sales Market Share by Application in 2020
Figure 84. Global Revenue Share of Mesalamine by Application (2016-2021)
Figure 85. Global Revenue Share of Mesalamine by Application in 2021
Figure 86. Allergan Total Revenue (US$ Million): 2020 Compared with 2018
Figure 87. Salix Pharmaceuticals Total Revenue (US$ Million): 2020 Compared with 2018
Figure 88. Nogra Pharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 89. AstraZeneca Total Revenue (US$ Million): 2020 Compared with 2018
Figure 90. Abbvie Total Revenue (US$ Million): 2020 Compared with 2018
Figure 91. Takeda Total Revenue (US$ Million): 2020 Compared with 2018
Figure 92. Janssen (Johnson & Johnson) Total Revenue (US$ Million): 2020 Compared with 2018
Figure 93. Pfizer Total Revenue (US$ Million): 2020 Compared with 2018
Figure 94. Ferring Total Revenue (US$ Million): 2020 Compared with 2018
Figure 95. Boehringer Ingelheim Total Revenue (US$ Million): 2020 Compared with 2018
Figure 96. Cosmo Pharmaceuticals Total Revenue (US$ Million): 2020 Compared with 2018
Figure 97. Teva Total Revenue (US$ Million): 2020 Compared with 2018
Figure 98. Mylan Total Revenue (US$ Million): 2020 Compared with 2018
Figure 99. Sandoz Mesalamine Total Revenue (US$ Million): 2020 Compared with 2018
Figure 100. Tillotts Pharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 101. Chiesi Farmaceutici Total Revenue (US$ Million): 2020 Compared with 2018
Figure 102. Dr Falk Pharma Total Revenue (US$ Million): 2020 Compared with 2018
Figure 103. Cipla Total Revenue (US$ Million): 2020 Compared with 2018
Figure 104. Synmosa Biopharma Corporation Total Revenue (US$ Million): 2020 Compared with 2018
Figure 105. Lunan Better Pharmaceutical Total Revenue (US$ Million): 2020 Compared with 2018
Figure 106. Shanghai Sine Promod Pharmaceutical Total Revenue (US$ Million): 2020 Compared with 2018
Figure 107. Price Trend of Key Raw Materials
Figure 108. Manufacturing Cost Structure of Mesalamine
Figure 109. Manufacturing Process Analysis of Mesalamine
Figure 110. Mesalamine Industrial Chain Analysis
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Porter's Five Forces Analysis
Figure 114. North America Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 115. North America Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 116. Europe Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 117. Europe Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 118. Latin America Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 119. Latin America Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 120. Middle East and Africa Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 121. Middle East and Africa Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 122. Asia Pacific Mesalamine Sales (KG) and Growth Rate Forecast (2021-2027)
Figure 123. Asia Pacific Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
Choose License Type
  • $4250  
  • $5850  
  • $7250  

Secure Payment


img1

Related Reports

Anti-Allergic Drugs Market

Report Description The Global Anti-Allergic Drugs Market Report provides Insightful information to t

Read More

Cannabis Pharmaceutical Market

Key Industry Insights This report is an extensive study that includes a detailed overview of the Can

Read More

Vaccine Packaging Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More